Bioavailability of Different Applications of Dabigatran in Healthy Volunteers
NCT02171611 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-05-23
Summary
To determine the relative bioavailability of 150 mg of dabigatran etexilate as pellets on food and of 150 mg of dabigatran etexilate as powder resolved in reconstitution solution, both with 150 mg of dabigatran etexilate as capsule in healthy volunteers
Conditions
- Healthy
Interventions
- DRUG
-
Dabigatran etexilate pellets
- DRUG
-
Dabigatran etexilate powder
- DRUG
-
Dabigatran etexilate capsule
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-05-31
More Related Trials
-
Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers
NCT02171052 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers
NCT02171533 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of Dabigatran With or Without Clarithromycin in Healthy Volunteers
NCT02171585 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body
NCT06791187 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants
NCT05123079 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.
NCT00713791 ·Status: COMPLETED ·Phase: PHASE1
-
A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult Participants
NCT02117505 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults
NCT05673889 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of 1 mg and 10 mg BI 1356 BS as Powder in the Bottle (PIB) to 1 mg and 10 mg BI 1356 BS as Tablets as Single Oral Administration in Healthy Male Volunteers Including the Influence of Food on the Bioavailability of 10 mg BI 1356 BS
NCT02180503 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 1015550 Following Oral Administration Under Fed and Fasted Conditions in Healthy Male Subjects
NCT03302078 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers
NCT02182414 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of SCY-078 on the PK of Dabigatran in Healthy Subjects
NCT04092725 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Effect of the Formulations (Orally Disintegrating Tablet and Film-coated Tablet) on Bioequivalence of Drug Rivaroxaban (Xarelto) at Dose of 10 mg in Japanese Healthy Male Adult Subjects
NCT04511611 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of K0706 in Healthy Subjects
NCT03316820 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants
NCT07229404 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study
NCT01602887 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulation, the Effect of Food on the Bioavailability of Branebrutinib From a Tablet Formulation, and the Safety and Drug Levels of Branebrutinib From a Tablet Formulation in Healthy Participants
NCT05303220 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501
NCT01549054 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe
NCT06050291 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Two Dosage Forms of LY2886721 in Healthy Participants
NCT01775904 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Learn How Much Rivaroxaban Gets Into the Blood When Taken in Different Forms and How Safe They Are in Healthy Men
NCT04727021 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects
NCT02034578 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX Administered as Multiple Doses and Safety and Pharmacokinetics of BIRT 2584 XX Administered With and Without Food as Single Dose to Healthy Male Volunteers
NCT02256761 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants
NCT02271425 ·Status: COMPLETED ·Phase: PHASE1